Antivenom availability, delays and use in Australia

Area of Science:

• Toxicology
• Emergency Medicine
• Pharmacology

Background:

• Antivenom is the primary treatment for snake envenoming.
• Availability and timely administration of antivenom are critical, especially in resource-limited settings.
• Snakebite management requires careful consideration due to the risk of anaphylaxis.

Purpose of the Study:

• To highlight the importance of early antivenom administration in snake envenoming.
• To identify impediments to effective antivenom treatment, including pre-hospital and in-hospital delays.
• To emphasize the role of rapid diagnosis and clinical assessment in optimizing antivenom use.

Main Methods:

• Review of factors affecting antivenom treatment efficacy.
• Analysis of delays in antivenom administration in the Australian context.
• Discussion of diagnostic and clinical assessment strategies.

Main Results:

• Effective antivenom treatment depends on early administration (within 2-6 hours in Australia).
• Significant delays occur in antivenom administration, averaging 2.5 hours post-hospital presentation.
• Remoteness, diagnostic delays, and administrative issues contribute to pre-hospital and in-hospital delays.

Conclusions:

• Improving antivenom treatment requires addressing administration delays, not just availability.
• Early diagnosis using bedside tests and rapid clinical assessment are key to effective antivenom use.
• Optimizing the use of antivenom can improve outcomes for snake envenoming patients.